Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Dell Technologies Director Silver Lake Partners V DE (AIV) L.P. Sells $15.3M of Stock
Silver Lake Partners V DE (AIV) L.P., Director, sold 26,539 shares of Dell Technologies Inc. at $571.90 to $580.76 a share (average $575.43) in 11 transactions, worth $15.3M in total on Oct 6, 2026. Shares held after the trade: 12,246 (-11.6%).
Calisa Acquisition M&A Deal with Goodvision AI Inc.
Calisa Acquisition Corp held an extraordinary general meeting where shareholders approved the Business Combination Agreement with Goodvision AI Inc. The transaction includes a merger where Goodvision will become a wholly owned subsidiary of the company, which will be renamed Goodvision AI Holding Limited. Shareholders also approved the issuance of shares for the deal and a redesignation of the company's authorized share capital.
Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $4.1M of Stock
Nippon Life Insurance Co, 10% Owner, bought 116,345 shares of Corebridge Financial, Inc. at $35.23 a share, worth $4.1M in total on Oct 6, 2026. Shares held after the trade: 126,786,106 (+0.1%).
Dell Technologies Director Silver Lake Technology Investors IV L.P. Sells $580K of Stock
Silver Lake Technology Investors IV L.P., Director, sold 1,009 shares of Dell Technologies Inc. at $571.90 to $579.63 a share (average $575.30) in 9 transactions, worth $580K in total on Oct 6, 2026. Shares held after the trade: 27 (-70.0%).
Dell Technologies Director Silver Lake Technology Investors V L.P. Sells $262K of Stock
Silver Lake Technology Investors V L.P., Director, sold 455 shares of Dell Technologies Inc. at $571.90 to $579.63 a share (average $575.31) in 9 transactions, worth $262K in total on Oct 6, 2026. Shares held after the trade: 12 (-70.0%).
Dell Technologies Director Sl SPV-2 L.P. Sells $26.7M of Stock
Sl SPV-2 L.P., Director, sold 46,323 shares of Dell Technologies Inc. at $571.90 to $580.76 a share (average $575.43) in 11 transactions, worth $26.7M in total on Oct 6, 2026. Shares held after the trade: 23,439 (-10.7%).
Analog Devices Insider Ray Stata Sells $1.17M of Stock
Ray Stata sold 2,832 shares of Analog Devices Inc at $405.57 to $421.24 a share (average $413.71) in 11 transactions, worth $1.17M in total between Oct 6, 2026 and Oct 7, 2026. Shares held after the trade: 107,457 (-0.1%).
Park Aerospace Corp. reported financial results for its 2027 fiscal year second quarter ended August 30, 2026, with net sales increasing to $20.8 million from $16.4 million in the prior year's second quarter. Net earnings for the quarter rose significantly to $4.5 million, or $0.21 per share, compared to $2.4 million, or $0.12 per share, in the same period last year.
Hercules Capital $400M Debt Financing with U.S. Bank Trust Company, National Association
Hercules Capital, Inc. completed the issuance and sale of $400 million in aggregate principal amount of 6.700% Notes due 2029. The notes are unsecured senior obligations maturing on October 8, 2029, and were issued under a Twelfth Supplemental Indenture with U.S. Bank Trust Company as trustee.
Brookdale Senior Living reported its September 2026 occupancy metrics, showing a consolidated weighted average occupancy of 83.4% and a month-end occupancy of 84.6%. For the full third quarter of 2026, weighted average consolidated occupancy grew 130 basis points year-over-year to 83.1%, outperforming sequential market trends reported by the National Investment Center for Seniors Housing & Care.
Devon Energy Divestiture to Crescent Energy Company for $4.2B
Devon Energy has entered into a definitive agreement to sell its Eagle Ford assets in South Texas to Crescent Energy Company for $4.2 billion in cash. The divestiture includes approximately 90,000 net acres and is intended to high-grade Devon's portfolio while providing proceeds to accelerate share repurchases and debt reduction.
EOG Resources updated its Q3 2026 guidance for current tax expense to a range of $835 million - $935 million, up from the previous forecast of $545 million - $645 million. The increase is driven by higher realized crude oil prices resulting from ongoing conflict in the Middle East. The company also reported receiving $40 million in net cash from commodity derivative settlements during the third quarter.
Zoetis Inc. declared a fourth quarter 2026 cash dividend of $0.53 per share. The dividend is scheduled to be paid on December 1, 2026, to shareholders of record as of October 30, 2026.
Tenax Therapeutics filed an updated investor presentation detailing strategic changes to its Phase 3 LEVEL-2 clinical trial for TNX-103 in PH-HFpEF. The company is pausing enrollment to amend protocol criteria based on findings from its completed LEVEL trial and has requested a Type C meeting with the FDA to discuss the development path.
Thomas Kim, Executive Vice President, Chief Legal Officer & Secretary of Gartner, Inc., notified the company on October 3, 2026, that he will be stepping down effective October 16, 2026. Mr. Kim is leaving to pursue a new senior executive opportunity, and the company stated there were no disagreements regarding financials or operations.
Oklo General Counsel & Secretary Vivek Narayanadas Sells $10.7K of Stock
Vivek Narayanadas, General Counsel & Secretary, sold 288 shares of Oklo Inc. at $37.29 a share, worth $10.7K in total on Oct 6, 2026. Shares held after the trade: 8,446 (-3.3%).
Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as a Class II director to its Board of Directors, effective October 7, 2026. Dr. Zhang brings over 25 years of experience in clinical strategy and biostatistics from roles at Abivax, Alumis, and MyoKardia. As a non-employee director, he will receive an annual cash retainer of $40,000 and an initial stock option grant valued at $500,000.
Appian CEO and President Matthew W. Calkins Sells $1.69M of Stock
Matthew W. Calkins, CEO and President, sold 45,000 shares of Appian Corp at $37.32 to $37.97 a share (average $37.50) in 2 transactions, worth $1.69M in total on Oct 7, 2026. Shares held after the trade: 1,584,144 (-0.8%).
Oil-Dri Corporation of America reported record annual net sales of $493.8 million and record net income of $57.0 million for fiscal year 2026. The company also declared quarterly cash dividends of $0.225 per share of Common Stock and $0.168 per share of Class B Stock, and appointed Anthony W. Parker as an executive officer.
Term
FY2026
“Fiscal year 2026 has been especially meaningful as we celebrated our 85th anniversary and reported our strongest full-year sales and net income in history. In the first half of the year, we faced difficult comparisons against a robust prior period. Our team remained focused on growing the business in the second half and ultimately delivered solid results that surpassed last year’s performance. The fourth quarter closed out the year on a high note, with record breaking sales.”
Daniel S. Jaffee, President and Chief Executive Officer
Quantum-Si announced it has successfully demonstrated the detection of 19 amino acids within its Proteus development program, a key technical milestone for its single-molecule protein sequencing platform. The company remains on track to demonstrate detection of all 20 amino acids by the end of 2026 and expects a commercial launch of the Proteus platform in the second quarter of 2027.
Trane Technologies Chair and CEO David S. Regnery Sells $23.1M of Stock
David S. Regnery, Chair and CEO, sold 48,091 shares of Trane Technologies plc at $480.00 a share, worth $23.1M in total on Oct 6, 2026. Shares held after the trade: 96,951 (-33.2%).
Calix, Inc. announced that its board of directors has authorized an additional $100 million for its existing stock repurchase program. The increase is intended to provide greater flexibility for the company's capital allocation strategy, allowing for repurchases through open market or private transactions based on market conditions.
StageWise Strategies Corp. entered into a definitive Share Exchange Agreement to acquire 99.99% of TEG SPV LLC, an Uzbekistan-based entity, from Tourism and Entertainment Group LLC and an individual seller. In exchange, the company will issue 183,098,434 shares of common stock, representing approximately 97.3% of the post-transaction outstanding shares. Upon closing, TEG SPV will become a subsidiary and its operations will become the principal business of the company.
Braemar Hotels & Resorts announced a definitive agreement to sell the Four Seasons Resort Scottsdale for $372 million as part of its strategic transition to a self-managed REIT. The company also released a comprehensive investor presentation titled 'A New Chapter for Braemar' and provided a 2027 financial outlook following its separation from Ashford Inc.
Pacific Biosciences of California Insider James R. Gibson II Sells $2.06M of Stock
James R. Gibson II sold 661,815 shares of Pacific Biosciences of California, Inc. at $3.11 a share, worth $2.06M in total on Oct 6, 2026. Shares held after the trade: 1,083,848 (-37.9%).
Rapport Therapeutics CEO Abraham Ceesay Sells $143K of Stock
Abraham Ceesay, CEO, sold 4,522 shares of Rapport Therapeutics, Inc. at $30.66 to $32.03 a share (average $31.68) in 2 transactions, worth $143K in total between Oct 6, 2026 and Oct 7, 2026. Shares held after the trade: 452,245 (-0.3%).
Mallun Yen sold 11,942 shares of Everpure, Inc. at $145.95 to $148.55 a share (average $146.97) in 4 transactions, worth $1.76M in total on Oct 6, 2026. Shares held after the trade: 31,339 (-0.9%).
Robert P. Crabb resigned as Secretary of KiNRG, Inc. effective October 2, 2026. Stephen Sadle, the company's current Chief Operating Officer and director, was appointed as the new Secretary to replace him.
Werner Enterprises $1.1B Debt Financing with BMO Bank, N.A.
Werner Enterprises entered into a new $1.1 billion unsecured credit facility maturing in October 2031, replacing its previous $1.075 billion facility. The company immediately borrowed $465 million under the new agreement at a weighted average interest rate of 5.54% to refinance existing debt and for general corporate purposes. The new agreement eliminates the 0.10% SOFR credit adjustment spread present in the prior 2022 facility.
Vireo Growth $60M Debt Financing with Needham Bank
Vireo Growth Inc. entered into a $60 million term loan agreement with Needham Bank at a fixed interest rate of 8.50% per annum. The proceeds were used to refinance $49 million of existing senior debt related to its New York cultivation facility and to finance the $11 million acquisition of its Palatka, Florida cultivation facility. The loan is secured by first-priority mortgages on these properties and matures in April 2034.